ClinicalTrials.gg
Drug

Regadenoson clinical trials

Also written Lexiscan and CVT3146.

studies test it
48
open now
3
in phase 3
4
first study started
2003

How each study uses regadenoson is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the regadenoson studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
10 Apr 2008 · LEXISCAN · NDA 022161 (FDA, Drugs@FDA)
European Union
6 Sept 2010 · Rapiscan · EMEA/H/C/001176 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Regadenoson
41

Brand

Lexiscan
35
Rapiscan
1

Development codes

CVT3146
7

Studies by the year they started

48 studies that test it; most in 2009 (11)

Studies that test regadenoson, by start year
YearStudies
20031
20041
200911
20103
20114
20125
20136
20144
20153
20161
20173
20192
20201
20213

By phase

A phase 1/2 study counts in both.

Early Phase 1
5
Phase 1
8
Phase 2
8
Phase 3
4
Phase 4
14
No phase
11

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 10 · Other 38

University of Maryland, Baltimore (3) · Astellas Pharma Inc (3) · University of Chicago (3) · University of Utah (3) · Gilead Sciences (3) · Emory University (2) · University of Nebraska (2) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (2)

Often tested with

Tested in the same studies.

Adenosine (5) · Water O-15 (2) · FS 069 (1) · Gadofosveset trisodium (1) · Temozolomide (1) · Exercise Pain Management (1) · Dobutamine (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 3

Studies that test regadenoson.

Studies

Open first, then newest update. How each study uses regadenoson is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 48

See all 48 studies that test regadenoson →

Given beside what is tested · 6 — regadenoson is usual care or a partner of the new treatment

Codes

What other systems call regadenoson · ClinicalTrials.gg INT004359

  • MeSH (NLM) C430916regadenosonConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) 2XLN4Y044HREGADENOSONConfirmed FDA, NLM, Wikidata
  • RxNorm 640062One source FDA
  • Wikidata Q83118320Regadenoson hydrateConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C74420RegadenosonOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.